From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

Sponsored by Edwards Lifesciences

Anchorperson: P. MacCarthy

Moderator: B. Prendergast

Summary

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key criteria at the time of first intervention for aortic stenosis will determine future treatment options, to learn how to select appropriate patients for aortic and mitral valve-in-valve procedures, and to discover the key procedural aspects of these valve-in-valve procedures.

Learning Objectives

To understand how key criteria at the time of first intervention for aortic stenosis will determine future treatment options
To learn how to select appropriate patients for aortic and mitral valve-in-valve procedures
To discover the key procedural aspects of these valve-in-valve procedures